Literature DB >> 8281220

Randomized evaluation of a low fat ad libitum carbohydrate diet for weight reduction.

D G Schlundt1, J O Hill, J Pope-Cordle, D Arnold, K L Virts, M Katahn.   

Abstract

Restricting dietary fat intake while consuming carbohydrates ad libitum has recently been promoted as a weight loss regimen. Sixty subjects (52 females and eight males) were randomized to low fat ad libitum carbohydrate (low-fat) or low fat with caloric restriction (low-calorie) behaviour modification treatments. Forty-nine subjects completed the 16-20 week programme. Subjects in both groups reported averaging over five exercise sessions per week during treatment. The low-calorie group lost significantly more weight (males 11.8 kg, s.d. 6.4; females 8.2 kg, s.d. 4.2) than the low-fat group (males 8.0 kg, s.d. 1.3; females 3.9 kg, s.d. 3.7). Both groups of subjects lost similar amounts of lean body mass. There was significantly greater loss of body fat in the low-calorie group. A slight reduction in RMR, adjusted for changes in lean body mass, was observed in both groups. Fat intake was reduced from 90 to 30 g per day. Subjects in both groups reduced their total energy intake with the low-calorie group consuming fewer calories per day than the low-fat group. Both groups showed significant and equivalent improvements in eating habits based on microanalysis of eating diaries. Eating in social situations and emotional eating, however, continued to cause adherence problems during treatment for both groups. Follow-up data collected 9-12 months after completion of treatment on 65% of the subjects completing the study showed no significant difference between the two groups in weight losses from baseline (low-fat group 2.6 kg; low-calorie group 5.5 kg).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8281220

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  16 in total

Review 1.  Effective management of obesity.

Authors:  S O'Meara; A M Glenny; C Wilson; A Melville; T A Sheldon
Journal:  Qual Health Care       Date:  1997-09

2.  Lifestyle modification in the management of obesity.

Authors:  Thomas A Wadden; Brian G McGuckin; Rebecca A Rothman; Stephanie L Sargent
Journal:  J Gastrointest Surg       Date:  2003 May-Jun       Impact factor: 3.452

Review 3.  acp Best Practice No 168. The investigation and management of obesity.

Authors:  M Labib
Journal:  J Clin Pathol       Date:  2003-01       Impact factor: 3.411

Review 4.  Diet modification for treatment and prevention of obesity.

Authors:  Rosane Ness-Abramof; Caroline M Apovian
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

5.  Differences in home food availability of high- and low-fat foods after a behavioral weight control program are regional not racial.

Authors:  Rebecca A Krukowski; Jean Harvey-Berino; Delia Smith West
Journal:  Int J Behav Nutr Phys Act       Date:  2010-09-24       Impact factor: 6.457

Review 6.  Impact of fat substitutes on fat intake.

Authors:  G D Miller; S M Groziak
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

7.  Body image and self-esteem among adolescents undergoing an intervention targeting dietary and physical activity behaviors.

Authors:  Jeannie S Huang; Gregory J Norman; Marion F Zabinski; Karen Calfas; Kevin Patrick
Journal:  J Adolesc Health       Date:  2007-01-05       Impact factor: 5.012

8.  Non-alcoholic fatty liver disease and the metabolic syndrome: effects of weight loss and a review of popular diets. Are low carbohydrate diets the answer?

Authors:  Harjot K Gill; George Y Wu
Journal:  World J Gastroenterol       Date:  2006-01-21       Impact factor: 5.742

Review 9.  The role of diet and exercise for the maintenance of fat-free mass and resting metabolic rate during weight loss.

Authors:  Petra Stiegler; Adam Cunliffe
Journal:  Sports Med       Date:  2006       Impact factor: 11.136

Review 10.  Screening and behavioral management: obesity and weight management.

Authors:  Robert Nicholson; Marcelo Bigal
Journal:  Headache       Date:  2008-01       Impact factor: 5.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.